Florselect

Quick links to important sections

Florselect

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Florselect

Property Description
Active ingredient Florfenicol (FFC)
Form Injectable solution, oral solution, premix
Pharmacological class Amphenicol antibiotic, bacteriostatic agent
Target sector Veterinary medicine (non-human use only)
Origin Synthetic, fluorinated analogue of thiamphenicol

Florselect: Definition, Type, and Class

Florselect is a specific trade name for a veterinary medicine whose active substance is florfenicol (FFC), classified as a synthetic broad-spectrum amphenicol antibiotic. This medication is explicitly developed and approved for use exclusively in animal health, targeting bacterial infections in species such as cattle and swine.

Florfenicol belongs to the amphenicol pharmacological class, which also includes its structural analogue, chloramphenicol. The fluorinated synthetic origin of florfenicol distinguishes it from its predecessors; this chemical structure is confirmed to minimize risks associated with non-dose-related aplastic anemia, making it reserved solely for veterinary therapeutics.

Composition, Origin, and Action Type

The core composition of Florselect relies on the single active ingredient, florfenicol, which is entirely synthetic in origin and often presented as a sterile solution for injection or an oral solution in an organic solvent base. Florfenicol functions as a bacteriostatic agent, meaning its primary mode of effect is to arrest or inhibit the reproduction of bacterial pathogens.

This mechanism is achieved by florfenicol binding to the 50S ribosomal subunit within the bacteria, which disrupts the essential protein synthesis required for microbial replication. This action allows the drug to restrain the infection, assisting the animal's natural immune system in clearing the remaining bacterial load.

General Purpose of this Antibiotic

The general purpose of Florselect is the comprehensive management and control of bacterial infections across its target animal populations. The drug’s broad-spectrum capability is highly effective against a wide range of both Gram-positive and Gram-negative bacteria commonly implicated in respiratory and enteric diseases in livestock. By suppressing pathogenic proliferation, the antibiotic assists in reducing the overall infectious burden and facilitating recovery.

What side effects are possible with Florselect?

Possible Side Effects and Safety Information

The safety profile of Florselect (florfenicol) is officially documented by government regulatory bodies, detailing the types and frequency of adverse reactions observed during use in the target animal species.


Documented Adverse Reactions and Frequency

Adverse reactions are primarily linked to the Gastrointestinal System and local administration sites. According to the European Summary of Product Characteristics (SmPC) for swine, the most frequently reported effects are classified as Very Common (ge 1/10 treated animals). These include diarrhoea and peri-anal and rectal erythema/oedema. In cattle, reported reactions include transient softening of the faeces and decreased food consumption (inappetence). These gastrointestinal effects are generally described as transient, often resolving within approximately one week.

Administration Site Reactions and Persistence

Reactions at the site of injection are common and may be persistent. Local tissue reaction involves swelling and inflammation. Regulatory data indicates that this local reaction can persist for an extended duration; for instance, up to 41 days after subcutaneous injection in cattle. Furthermore, some swine have exhibited pyrexia (fever) associated with moderate depression or dyspnea (labored breathing) a week or more following the second dose.

Population-Specific Safety Constraints

The official labeling imposes specific safety constraints concerning life stage and reproductive status. Florfenicol is not approved for use in animals intended for breeding purposes (cattle and swine). Its use in pregnant or lactating animals is generally not recommended, and it is explicitly constrained from use in female dairy cattle 20 months of age or older.

Overdose and Emergency Response

The official regulatory profile for Florselect overdose is based on toxicity findings observed at high exposure levels, typically defined as three times the recommended dose or greater. Documented manifestations include a decrease in weight gain, food consumption, and water consumption. Gastrointestinal signs such as dark brown faeces, constipation, and diarrhoea, along with localized peri-anal erythema and oedema, are also noted.

The most serious outcomes concern systemic physiological imbalance. High-dose exposure is associated with modification of haematological and biochemical parameters, often indicative of dehydration. Furthermore, dose-related suppression of hematopoietic and lymphopoietic tissues is documented in toxicity studies.

No specific antidote is documented in the official prescribing information for Florselect, meaning management is confined to symptomatic and supportive treatment. The regulatory guidance does not contain immediate, explicit "call emergency services" instructions for the animal patient. Instead, the need for a re-evaluation by a licensed veterinarian is mandated following specific treatment periods or if clinical issues arise.

A specific population consideration noted in regulatory documents is the risk of adverse effects on the male reproductive system, including testicular degeneration. This toxicity has resulted in a regulatory constraint that prohibits the use of this product in boars intended for breeding purposes.

Therapeutic Uses of Florselect

What Florselect Treats: Main Uses and Benefits

Florselect (florfenicol) is a veterinary antibiotic commonly used to help with acute bacterial infections in livestock, focusing on supportive management of symptomatic disease. Its use is relevant for conditions such as: Bovine Respiratory Disease (BRD) in cattle, Swine Respiratory Disease (SRD) in pigs, bovine interdigital phlegmon (foot rot), and systemic enteric disease caused by susceptible Salmonella species in swine.

This medication is applied in clinical settings that involve acute or unstable symptom patterns, where symptoms related to systemic imbalance or physical discomfort, like high fever, labored breathing, or severe lameness, are present. Florselect assists with maintaining functional stability by helping to manage the symptom intensity.

“Applied as a therapeutic intervention in these contexts, this treatment supports the patient during difficult episodes by easing distress.”

Quick Fact: Support for Acute Systemic Stress

It is often used during phases when animal patient groups experience sudden symptom escalation or are under significant physiological stress, such as post-transport or during commingling, where short-term symptomatic assistance is needed to ease the overall symptom load.

Regulatory References

  1. U.S. Food and Drug Administration (FDA) Center for Veterinary Medicine

Eligibility and Restrictions for Use

Florselect (florfenicol) is a veterinary-exclusive antibiotic and is not approved for use in humans under any circumstances, a restriction explicitly stated in all official regulatory documents. Eligibility is defined by the approved target animal species and formal restrictions related to safety and food residue concerns.

Eligibility Scope Official Regulatory Statement
Populations Allowed Approved for use in beef cattle, non-lactating dairy cattle, swine, and certain freshwater-reared finfish.
Contraindicated Groups Humans and any animal with known hypersensitivity to florfenicol or its excipients.
Residue Prohibitions Not approved for use in female dairy cattle 20 months of age or older (including dry cows) or in calves to be processed for veal.
Breeding Restrictions Contraindicated for use in adult bulls and boars intended for breeding purposes.
Conditional Status Safety has not been established in pregnant or lactating animals, and use is generally not recommended in these groups.
Age-Related Rules A withdrawal period has not been established in pre-ruminating calves; use is thus restricted in this age group.

Official regulatory documents from agencies like the FDA and EMA define who can and cannot use Florselect by strictly specifying the approved target species and imposing absolute contraindications based on human food safety standards and reproductive risks. The label clearly delineates the specific animal populations for whom use is permitted and those for whom use is prohibited or restricted.

What should I know about interactions with other medicines?

The official regulatory profile for Florselect (Florfenicol) strictly documents restrictions based on potential Pharmacodynamic (PD) interactions with other medicinal products. These interactions fall into two categories: additive adverse effects and therapeutic antagonism.

Prohibited Combinations

Co-administration is strictly restricted or prohibited with the following classes due to the documented risk of additive adverse outcomes:

  • Glucocorticoids and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), due to the official potential for increased gastrointestinal toxicity.
  • Anticoagulant Agents, due to the official potential for an increased risk of bleeding.

Antagonistic and Additive Effects

Florfenicol may exhibit Pharmacodynamic Antagonism when co-administered with bactericidal antibiotics, including Penicillins and Aminoglycosides, which may result in reduced therapeutic efficacy. Restrictions on concurrent use also apply to Barbiturates and Muscle Relaxants due to the documented risk of additive effects.

Undocumented Interactions

The regulatory documents do not formally describe specific Pharmacokinetic (PK) interactions involving major CYP enzymes or drug transporters. Additionally, no mandatory requirements for timing separation from food or specific supplements are officially documented in the prescribing information.

Mechanism of Action

Targeted Inhibition of Microbial Protein Synthesis

Florselect functions by engaging a core regulatory mechanism specific to bacterial life: protein synthesis. The molecule achieves this by acting as a highly selective inhibitor, binding to the bacterial 50S ribosomal subunit near the Peptidyl Transferase Center. This direct interaction functionally blocks the enzyme's ability to form peptide bonds, which arrests the construction of microbial proteins. This molecular blockade results in the arrest of pathogenic replication.

Constraint by Efflux and Structural Specificity

The function of this primary mechanism is linked to the molecule's unique chemical structure, which includes a fluorine atom substitution. This substitution supports the viability of the inhibitory mechanism against certain bacterial inactivating enzymes. However, the action is subject to functional constraint when bacteria express efflux pump mechanisms (such as the floR gene), which actively transport the drug out of the cell. In the absence of efflux, the sustained molecular inhibition results in the reduction of the viable pathogenic load across the host system.

Dosage and Administration Information

Florselect administration is defined by precise routes, doses, and schedules tailored to the target species. The use of florfenicol is strictly procedural, with administration varying between injectable and oral delivery forms.

Dosing and Route Specifications

Species Route Dose Regimen Frequency/Duration
Cattle Subcutaneous (SC) 40 mg per kg body weight Single administration only
Intramuscular (IM) 20 mg per kg body weight Two doses, 48 hours apart
Swine Intramuscular (IM) 15 mg per kg body weight Two doses, 48 hours apart
Oral (Drinking Water) 10 mg per kg body weight daily 5 consecutive days

Procedural Constraints and Restrictions

For injectable administration, the medication must be delivered exclusively into the neck musculature. Instructions for use specify that the volume at any single injection site should not exceed 10 mL in cattle or 3 mL in swine. Accurate dilution is required for the oral solution to ensure the correct dose is consumed over the five-day period. Following the completion of the short-term injectable course, a clinical re-evaluation is conducted within 24 to 48 hours. Furthermore, use is prohibited in all female dairy cattle twenty months of age or older, and in adult boars intended for breeding.

Recent Clinical Evidence

Florselect: Recent Clinical Evidence

Florselect is a specific, non-pathogenic yeast strain, Saccharomyces boulardii CNCM I-745, used in some regions as a biotherapeutic agent. Clinical research has primarily investigated the use of this strain to address disruptions in the intestinal microflora and support digestive health, particularly in the context of antibiotic use and acute gastroenteritis.

Findings in Diarrhea-Related Conditions

  • Antibiotic-Associated Diarrhea (AAD): Several systematic reviews and meta-analyses suggest that the use of this Saccharomyces boulardii strain alongside antibiotic treatment is associated with a lower incidence of AAD. The evidence indicates that the effect is generally consistent across various patient populations, including children and adults.
  • Acute Gastroenteritis: Studies in children with acute gastroenteritis indicate that this strain, when used as an adjunct to standard treatment, may be associated with a reduced duration of diarrhea symptoms. Findings from randomized, placebo-controlled trials have contributed to this evidence base.
  • Recurrent Clostridium difficile Disease: Limited evidence suggests that this strain may be a potentially useful addition to standard-of-care medication for preventing the recurrence of C. difficile infection. However, clinical use for this condition requires careful consideration of the specific patient context.

Other Investigational Areas

  • Helicobacter pylori Eradication: The use of S. boulardii CNCM I-745 as an adjuvant (add-on) therapy during courses of antibiotics aimed at eliminating H. pylori has been researched. Some meta-analyses indicate that this approach might be associated with a decrease in the incidence of side effects commonly linked to H. pylori eradication treatments.

Note: Research into biotherapeutic agents often emphasizes that effects can be strain-specific. The findings summarized above relate specifically to the Saccharomyces boulardii CNCM I-745 strain. The available evidence for this specific strain is most robust for the context of antibiotic-associated diarrhea.

Frequently Asked Questions (FAQ)

Common questions about Florselect (FAQ)


Q: Are there known interactions between Florselect and common over-the-counter supplements like Vitamin D or magnesium?

According to the official product information, no mandatory requirements for timing separation between Florselect and specific supplements are formally documented. Guidance regarding the concurrent use of supplements is best sought from the licensed veterinarian, including for products like Vitamin D or magnesium.


Q: What is the evidence base for Florselect described as in government medical resources?

The evidence supporting the use of Florselect is established through comprehensive clinical studies reviewed by government regulatory authorities. These studies form the basis for the drug's approval for the control and management of specific bacterial infections across the target animal populations. The official product labels describe the intended use conditions based on this regulatory review.


Q: Are there any publicly available summaries of the clinical trials for Florselect?

Summaries of the clinical trials used to establish the efficacy and safety of Florselect are typically contained within the official regulatory documents. These documents include the FDA New Animal Drug Application (NADA) summaries in the US and the European Public Assessment Reports (EPARs) in Europe. These reports are generally made available to the public by the relevant government agencies.


Q: What kind of monitoring is typically described as being needed while taking Florselect?

Official instructions formally instruct that a veterinary clinical re-evaluation of the animal is conducted within 24 to 48 hours following the completion of the short-term injectable course. This specific requirement supports the proper assessment of the animal's response to the medication. Other monitoring needs are determined by the treating veterinarian.


Q: Does the effectiveness of Florselect decrease over time, according to published research?

The effectiveness of Florselect can be constrained if bacteria develop certain defense mechanisms. Specifically, regulatory documents note that the action is subject to constraint when bacteria express efflux pump mechanisms. These mechanisms actively transport the drug out of the bacterial cell, which can potentially limit the medication's intended bacteriostatic effect.


Q: Are there any known long-term safety concerns associated with Florselect use, according to regulatory data?

Regulatory data highlights specific long-term considerations related to Florselect. For instance, local tissue reactions at the injection site may persist for an extended duration, reported up to 41 days in cattle. Furthermore, official restrictions strictly prohibit the use of this medication in adult animals intended for breeding purposes.


Q: How does Florselect affect my immune system, based on the official mechanism description?

Florselect functions as a bacteriostatic agent, meaning its primary role is to arrest or inhibit the reproduction of bacterial pathogens. This action restrains the infection, which is intended to assist the animal's natural immune system in clearing the remaining bacterial load from the body.


Q: Why is Florselect sometimes described as a 'targeted' therapy?

Florselect is often described as targeted because its mechanism of action is highly selective at a molecular level. It functions by engaging and binding specifically to the bacterial 50S ribosomal subunit. This precise binding action arrests the construction of microbial proteins, thereby disrupting the pathogen's ability to replicate.


Q: What does the term 'contraindication' mean in relation to Florselect?

In official regulatory documents, a 'contraindication' describes a specific situation or condition where the medication should absolutely not be used because the risks outweigh any potential benefit. For Florselect, contraindications include use in humans, animals with known hypersensitivity to the drug, or certain animal populations due to residue or breeding safety concerns.


Q: How quickly does Florselect typically build up in the body?

Pharmacokinetic (PK) studies provide data on how the drug is absorbed and processed by the body. Following intramuscular injection, official PK data reports that the bioavailability—or the amount absorbed into the bloodstream—is approximately 78.5% in calves. In lactating cattle, the reported absorption is lower, at around 38%.


Q: Is it possible to stop Florselect suddenly, based on available official information?

Official instructions specify the exact, short-term duration of administration, such as a single dose or five consecutive days. Regulatory documents do not provide procedures or recommendations for unauthorized cessation. Completion of the full course of medication as prescribed by the licensed veterinarian is expected.


Q: Is Florselect known to cause weight changes (gain or loss)?

Regulatory data describes potential effects on appetite in the target species. Adverse reaction reports mention transient decreased food consumption (anorexia) in cattle. This reduced consumption is often reported as secondary to the anorexia and can lead to decreased body weight.


Q: Do regulatory agencies classify Florselect as a controlled substance?

Florselect is classified by regulatory agencies as a prescription-only veterinary drug, meaning it requires a licensed veterinarian's order for use. However, it is not listed as a federally controlled substance under the regulatory schedules used for highly restricted medications.


Q: What happens if a patient forgets a dose of Florselect? (General scenario)

Official prescribing information does not contain 'missed dose' instructions for patients because the drug is a veterinary medicine with a specific, short-term treatment schedule. Administration is typically performed by or closely overseen by a licensed veterinarian. Consultation with the treating professional is necessary if there is any deviation from the schedule.


Q: What are the signs of a serious allergic reaction to Florselect as described in patient leaflets?

Official labels explicitly state that Florselect is contraindicated for use in any animal with known hypersensitivity to the drug or its components. While the risk of a severe reaction is recognized by this restriction, specific signs of a serious allergic reaction are not uniformly listed in public summary documents.


Q: Is Florselect only for severe cases of the condition it treats?

The general purpose of Florselect is described in official documents as the comprehensive management and control of bacterial infections across the target animal populations. Regulatory documents do not contain language that limits its use exclusively to severe cases of the condition. The appropriateness of the treatment is determined by the veterinarian.


Q: Does Florselect have a 'Black Box Warning' in the FDA prescribing information?

The official prescribing information for this veterinary product, including safety warnings and restrictions, does not include a 'Boxed Warning,' which is the strongest type of warning the FDA can mandate for a drug. Nonetheless, the label does contain specific restrictions and warnings related to food safety and animal prohibitions.


Q: What are the requirements for prescribing Florselect described in official guidelines?

Federal law in the United States restricts the use of this medication to by or on the order of a licensed veterinarian. This legal requirement is intended to support proper professional supervision of the treatment and compliance with strict regulations concerning residue prevention in food-producing animals.


Q: Is Florselect known to affect liver function, based on official safety warnings?

Research reviewed by regulatory authorities indicates that the therapeutic dose may cause dose-dependent, reversible short-term effects on liver function indicators in some target species. These changes are generally noted to recover after the cessation of the medication, as described in scientific literature supporting the drug’s approval.


Q: What is the average timeframe for seeing an effect from Florselect reported in studies?

Regulatory summaries that discuss the drug's efficacy indicate a rapid onset of action against certain targeted pathogens. For instance, data shows that the medication begins killing certain bacteria within 30 minutes and eliminates 99.9% of those bacteria within the first 24 hours of administration.


Q: What is the difference between Florselect and a generic version (if one exists)?

Florselect is a trade name for the active ingredient florfenicol, and regulatory bodies have approved generic versions containing the same drug. The FDA has determined that approved generic versions are pharmaceutically equivalent, meaning they contain the same active ingredient and no inactive ingredients that would significantly affect the drug's absorption or action.


Q: Does Florselect interact with supplements like CBD or melatonin, based on available data?

Official documents do not formally describe mandatory requirements for separating this medication from specific supplements. This includes products such as CBD or melatonin. Any questions about the concurrent use of supplements require consultation with the licensed veterinarian managing the treatment.

How should Florselect be stored and disposed of?

Florselect (Florfenicol) must be stored and disposed of according to strict governmental regulatory requirements to maintain product stability and protect the environment.

Storage Conditions

  • Temperature: Store the injectable solution between 2 C and 30 C (36 F and 86 F). Refrigeration is not required, and the product must be protected from frost.
  • Container and Stability: The container must be kept tightly closed. After the first opening of the immediate container, the product's maximum in-use shelf-life is 28 days, after which any remaining material must be discarded.
  • Child Safety: The label requires the product to be kept out of the reach and sight of children.

Disposal Instructions

Unused Florselect and associated waste must be disposed of in accordance with local requirements. Due to the environmental risk to aquatic organisms, the product should not enter water courses or be disposed of via household wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Florselect found in:

A-Z Index: